Skip to main content

Table 2 Neurological findings

From: Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study

Finding

≤13 years (n = 40)

14-17 years (n = 11)

18+ years (n = 24)

Total (all patients, n = 75)

n (%)

n (%)

n (%)

n (%)

At least one of the following

33 (82.5)

9 (81.8)

11 (45.8)

53 (69.7)

Ataxia

4 (10.0)

0

1 (4.2)

5 (6.6)

Spasticity

0

0

0

0

Impaired fine motor skills

26 (65.0)

9 (81.8)

5 (20.8)

40 (52.6)

Muscle tonus disorders

3 (7.5)

1 (9.1)

0

4 (5.3)

Others

24 (60.0)

6 (54.5)

9 (37.5)

39 (51.3)

  1. These conditions were established by treating physicians
  2. Spasticity was defined as spastic paresis or occurrence of pyramidal signs
  3. Multiple answers were possible. “Other” neurological findings were not further specified by documenting physicians